solpadeine plus capsules
omega pharma limited - caffeine, paracetamol, codeine phosphate, hemihydrate - capsule - caffeine 30 milligram(s) ; paracetamol 500 milligram(s) ; codeine phosphate hemihydrate 8 milligram(s) - analgesics
solpa-plus with caffeine soluble tablets paracetamol 500 mg codeine phosphate hemihydrate 12.8 mg caffeine 30 mg
chefaro ireland dac - paracetamol; codeine phosphate hemihydrate; caffeine - effervescent tablet - 500 /12.8 /30 milligram(s) - opioids in combination with non-opioid analgesics; codeine and paracetamol
tylenol with codeine no. 2 - tab tablet
janssen inc - codeine phosphate; caffeine; acetaminophen - tablet - 15mg; 15mg; 300mg - codeine phosphate 15mg; caffeine 15mg; acetaminophen 300mg - opiate agonists
acetaminophene codeine et cafeine caplets tablet
laboratoire riva inc. - acetaminophen; codeine phosphate; caffeine citrate - tablet - 325mg; 8mg; 30mg - acetaminophen 325mg; codeine phosphate 8mg; caffeine citrate 30mg - opiate agonists
acetaminophene codeine et cafeine fort tablet
laboratoire riva inc. - acetaminophen; codeine phosphate; caffeine citrate - tablet - 500mg; 8mg; 30mg - acetaminophen 500mg; codeine phosphate 8mg; caffeine citrate 30mg - opiate agonists
caffeine citrate solution
fresenius kabi usa, llc - caffeine citrate (unii: u26eo4675q) (caffeine - unii:3g6a5w338e) - caffeine citrate 20 mg in 1 ml - caffeine citrate oral solution is indicated for the short term treatment of apnea of prematurity in infants between 28 and <33 weeks gestational age. caffeine citrate is contraindicated in patients who have demonstrated hypersensitivity to any of its components.
rokacet
taro pharmaceutical industries ltd - caffeine; codeine phosphate; paracetamol - caplets - paracetamol 500 mg; caffeine 30 mg; codeine phosphate 10 mg - paracetamol - paracetamol - for the relief of pain and coughs and for the reduction of fever accompanied by pain.
maxilief effervescent tablets paracetamol 500mg codeine phosphate hemihydrate 8mg caffeine 30mg
clonmel healthcare ltd - paracetamol; codeine phosphate hemihydrate; caffeine - effervescent tablet - 500/8/30 milligram(s) - anilides; paracetamol, combinations excl. psycholeptics
carisoprodol, aspirin and codeine phosphate- carisoprodol, aspirin and codeine phosphate tablet
rising pharmaceuticals, inc. - carisoprodol (unii: 21925k482h) (carisoprodol - unii:21925k482h), aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - carisoprodol 200 mg - carisoprodol, aspirin and codeine phosphate tablets, usp are indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. limitations of use because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses (seewarnings ), reserve carisoprodol, aspirin and codeine phosphate tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics): - have not been tolerated, or are not expected to be tolerated, - have not provided adequate analgesia, or are not expected to provide adequate analgesia carisoprodol, aspirin and codeine phosphate tablets,usp should only be used for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use has not been established and because acute, painful musculoskeletal conditions are generally of short duration (see dosage and administration ). carisoprodol, aspirin and codeine phosphate tablets are contraindicated for: - all children
caffeine and sodium benzoate injection, solution
american regent, inc. - caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - caffeine 125 mg in 1 ml - caffeine and sodium benzoate injection has been used in conjunction with supportive measure to treat respiratory depression associated with overdosage with cns depressant drugs (e.g., narcotic analgesics, alcohol). however, because of questionable benefit and transient action, most authorities believe caffeine and other analeptics should not be used in these conditions and recommend other supportive therapy. none known.